Missed GME or NVDA? Donโt Miss the Next One.โ
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
HLXB Stock Forecast 2025-2026
$10.85
Current Price
$255.07M
Market Cap
Buy 0
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to HLXB Price Targets
N/A
To High Target of $N/A
N/A
To Median Target of $N/A
N/A
To Low Target of $N/A
HLXB Price Momentum
0.0%
1 Week Change
+0.6%
1 Month Change
+4.9%
1 Year Change
+3.3%
Year-to-Date Change
-6.4%
From 52W High of $11.59
+7.0%
From 52W Low of $10.14
๐ MARKET SELLOFF ALERT
10 Quality Stocks Worth Considering Now
Researching Helix Acquisition II (HLXB) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on HLXB and similar high-potential opportunities.
Latest HLXB Stock Price Targets & Analyst Predictions
HLXB has shown a year-to-date change of 3.3% and a 1-year change of 4.9%, reflecting upward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for HLXB. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
HLXB Analyst Ratings
0
Buy
0
Hold
0
Sell
HLXB Price Target Range
Low
N/A
Average
N/A
High
N/A
Current: $10.85
Latest HLXB Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for HLXB.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|
Helix Acquisition Corp II (HLXB) Competitors
The following stocks are similar to Helix Acquisition II based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Helix Acquisition Corp II (HLXB) Financial Data
Helix Acquisition Corp II has a market capitalization of $255.07M with a P/E ratio of 30.1x. The company generates $0 in trailing twelve-month revenue with a 0.0% profit margin.
Revenue growth is N/A quarter-over-quarter, while maintaining an operating margin of 0.0% and return on equity of +4.0%.
Valuation Metrics
Market Cap
$255.07M
Enterprise Value
$253.37M
P/E Ratio
30.1x
PEG Ratio
0.0x
Price/Sales
0.0x
Growth & Margins
Revenue Growth (YoY)
N/A
Gross Margin
N/A
Operating Margin
0.0%
Net Margin
0.0%
EPS Growth
N/A
Financial Health
Cash/Price Ratio
+0.7%
Current Ratio
10.4x
Debt/Equity
0.0x
ROE
+4.0%
ROA
-0.5%
๐ฐ DON'T MISS THIS OPPORTUNITY
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Helix Acquisition Corp II (HLXB) Business Model
About Helix Acquisition Corp II
What They Do
Facilitates mergers in healthcare and life sciences.
Business Model
Helix Acquisition Corp II operates as a special purpose acquisition company (SPAC), raising capital through an IPO to find and merge with promising businesses in the healthcare and life sciences sectors. By doing so, it enables these companies to go public without the traditional IPO process, potentially enhancing their growth opportunities.
Additional Information
The company focuses on sectors such as biotechnology, pharmaceuticals, and medical technologies, leveraging its managerial expertise to identify high-growth potential companies. Helix Acquisition Corp II provides a streamlined pathway for private companies to access public markets, aligning with the growing trend of SPACs as alternative investment vehicles.
Helix Acquisition Corp II (HLXB) Latest News & Analysis
Latest News
Quick Summary
BridgeBio Oncology Therapeutics and Helix Acquisition Corp. II have announced a definitive business combination, advancing BridgeBio's pipeline of therapeutics targeting RAS and PI3Kฮฑ malignancies.
Why It Matters
The merger between BridgeBio Oncology and Helix Acquisition Corp. could enhance funding and accelerate drug development, impacting stock performance and market sentiment in biotech.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Helix Acquisition Corp. II closed its IPO on February 13, 2024, raising $184 million by offering 18.4 million Class A shares at $10 each, including an over-allotment of 2.4 million shares.
Why It Matters
Helix Acquisition Corp. II raised $184 million through its IPO, enhancing its capital for investments and growth, which could drive future share value and investor interest.
Source: Business Wire
Market Sentiment:
Neutral
Frequently Asked Questions About HLXB Stock
What is Helix Acquisition Corp II's (HLXB) stock forecast for 2025?
Analyst forecasts for Helix Acquisition Corp II (HLXB) are not currently available. The stock is trading at $10.85.
Is HLXB stock a good investment in 2025?
Analyst ratings for HLXB are not currently available. The stock is currently trading at $10.85. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for HLXB stock?
Price predictions from Wall Street analysts for HLXB are not currently available. The stock is trading at $10.85.
What is Helix Acquisition Corp II's business model?
Helix Acquisition Corp II operates as a special purpose acquisition company (SPAC), raising capital through an IPO to find and merge with promising businesses in the healthcare and life sciences sectors. By doing so, it enables these companies to go public without the traditional IPO process, potentially enhancing their growth opportunities.
What is the highest forecasted price for HLXB Helix Acquisition Corp II?
Price targets from Wall Street analysts for HLXB are not currently available. The stock is trading at $10.85.
What is the lowest forecasted price for HLXB Helix Acquisition Corp II?
Price targets from Wall Street analysts for HLXB are not currently available. The stock is trading at $10.85.
What is the overall HLXB consensus from analysts for Helix Acquisition Corp II?
Analyst ratings for HLXB are not currently available. The stock is trading at $10.85.
How accurate are HLXB stock price projections?
Stock price projections, including those for Helix Acquisition Corp II, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: May 16, 2025 12:53 AM UTC